You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
同方康泰(1312.HK)直線拉昇漲近20% 科技部建議儘快將磷酸氯喹納入新一版診療指南
格隆匯 02-17 15:43
格隆匯2月17日丨同方康泰(1312.HK)直線拉昇漲近20%,報0.173港元,最新總市值逼近10億港元。科技部生物中心副主任孫燕榮在會上表示,療效專家組經過認真細緻的研討,最後達成一致意見,一致認為磷酸氯喹是一個上市多年的老藥,用於廣泛人羣治療的安全性是可控的。基於前期臨牀機構所開展的臨牀研究,結果可以明確磷酸氯喹治療新冠肺炎具有療效。基於當前臨牀救治的迫切需求,專家一致推薦,應當儘快將磷酸氯喹納入到新一版的診療指南,擴大臨牀適用範圍。同方康泰間接非全資附屬公司重慶康樂製藥早前已獲國家藥品監督管理局認可為生產原料藥磷酸氯喹的單位。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account